Ceresini, G
Gemcitabine Galactose-modified Gemcitabine also called senescence-specific killing compound 1 (SSK1) decreases senescent cells viability in multiple cell types, in mice and human in vitro models as well as in a broad range of inductions such as irradiation, replicative exhaustion, OIS and oxidative or genotoxic stress
The Lancet, Volume 402, Issue 10403, 720730
As reviewed in Azzini et al (2020), an intervention study by Sun et al demonstrated that supplementation of 800g/day of folic acid improved autism symptoms and reduced homocysteine plasma levels
The homogenate was centrifuged for 10 min at 1,000rcf at 4C
The mechanism of MS pathology involves complex interactions between systems and cell types, such as neurons, glia, and immune cells, which lead to focal lesions of inflammatory demyelination and widespread neurodegeneration in the brain and spinal cord